Quidel Corp (QDEL) Tops Q3 EPS by 21c, Slight Beat on Revenues
Get Alerts QDEL Hot Sheet
Price: $39.08 -0.1%
Revenue Growth %: -16.4%
Financial Fact:
General and administrative: 6.56M
Today's EPS Names:
SFST, VLTO, CLIR, More
Revenue Growth %: -16.4%
Financial Fact:
General and administrative: 6.56M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Quidel Corp (NASDAQ: QDEL) reported Q3 EPS of $0.17, $0.21 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $50.9 million versus the consensus estimate of $50.26 million.
Third Quarter 2017 Financial Highlights
- Total revenue was $50.9 million as compared to $49.3 million in the third quarter of 2016.
- Total Immunoassay product revenue increased 19% from the third quarter of 2016.
- Total Molecular revenues increased 13% from the third quarter of 2016.
- Reported GAAP EPS of $(0.16) per share in the third quarter of 2017, as compared to $(0.02) per share in the third quarter of 2016 and reported non-GAAP EPS of $0.17 per diluted share in the third quarter of 2017, as compared to $0.10 per diluted share in the third quarter of 2016.
For earnings history and earnings-related data on Quidel Corp (QDEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novartis (NVS) Tops Q1 EPS by 13c, raises guidance
- JPMorgan is worried about further S&P 500 sell-off potential
- Globe Life Inc. (GL) Misses Q1 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!